Poliorix

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, StreptococcalPoliomyelitis

Phase 1

Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants

CompletedNCT00937404

GlaxoSmithKlinePoliomyelitis

Start: 2009-08-04End: 2009-11-13Updated: 2018-12-17

Phase 3

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

CompletedNCT00547248

GlaxoSmithKlineInfections, Streptococcal

Start: 2007-10-22End: 2008-10-07Updated: 2019-01-14

Related Papers

Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.

2016-02-0911 citations